Cefpodoxime Proxetil + Clavulanic Acid
Indications
Cefpodoxime Proxetil + Clavulanic Acid is indicated in these infections: acute bacterial exacerbation of chronic bronchitis, acute community acquired pneumonia, pharyngitis or tonsillitis, skin and soft tissue infections, urinary tract infections, uncomplicated gonorrhea, and acute maxillary sinusitis.
⚠️ Always consult a registered physician before taking any medicine.
Pharmacology
Cefpodoxime is a semi-synthetic, third generation cephalosporin. It works against several Gram positive and Gram negative microorganisms, and it stays stable in the presence of beta lactamase. Cefpodoxime is especially active against methicillin susceptible Staphylococci, Streptococcus pneumoniae, Haemophilus influenzae, Neisseria spp. and Moraxella catarrhalis.
Clavulanic acid is a natural beta lactamase inhibitor, produced by Streptomyces clavuligerus. It binds to beta lactamase moieties and inactivates them, so cefpodoxime is protected from being destroyed.
Pregnancy & Breastfeeding
Cefpodoxime and Clavulanic Acid falls under US FDA pregnancy category B. That said, there are no adequate and well-controlled studies in pregnant women. Animal reproduction studies don't always predict how a human will respond, so the medicine should be used during pregnancy only if it is clearly needed.
Cefpodoxime has been shown to pass into human milk. So caution should be exercised when Cefpodoxime is given to a nursing woman.
⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.
Dosage Reference
⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.
Side Effects & Interactions
Side Effects
No side-effect data recorded yet.